CRA’s Walter Colasante, Pascale Diesel, and Lev Gerlovin recently published a series of three articles in Cell & Gene on emerging gene and cell therapies and their impact on the market. Read the full series below.
How are cell and gene therapies changing drug development models?
New approaches to market access and reimbursement for gene and cell therapies
Four emerging commercialization strategies for gene and cell therapies
Gene therapy competitive dynamics: Winner takes all?
This article was originally published in Cell & Gene. It has also been published in Cell & Gene‘s sister publication, OutSourced Pharama. With many gene...